Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hilton

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Cancer Research|February 6, 2013
mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesisDebasmita Roy, Sang-Hoon Sin, Amy Lucas, et al.
Science Advances|August 25, 2020
Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effectsSangsin Lee, Ning Ding, Yidi Sun, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Tailoring a CRISPR/Cas-based Epigenome Editor for Programmable Chromatin Acylation and Decreased CytotoxicityJacob Goell, Jing Li, Barun Mahata, et al.
Scientific Reports|February 17, 2017
Cu<sup>II</sup>(atsm) improves the neurological phenotype and survival of SOD1<sup>G93A</sup> mice and selectively increases enzymatically active SOD1 in the spinal cordJames B Hilton, Stephen W Mercer, Nastasia K H Lim, et al.
Human Molecular Genetics|March 18, 2014
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brainNastasia K H Lim, Lin W Hung, Terence Y Pang, et al.
ACS Synthetic Biology|February 3, 2025
Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T CellsRosa Selenia Guerra-Resendez, Samantha LeGoff Lydon, Alex J Ma, et al.
Journal of the American Chemical Society|December 21, 2022
Multiplex Base-Editing Enables Combinatorial Epigenetic Regulation for Genome Mining of Fungal Natural ProductsFanglong Zhao, Chunxiao Sun, Zhiwen Liu, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Persistent tailoring of MSC activation through genetic primingMichael A Beauregard, Guy C Bedford, Daniel A Brenner, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
Persistent tailoring of MSC activation through genetic primingMichael A Beauregard, Guy C Bedford, Daniel A Brenner, et al.
Nature Methods|October 9, 2023
Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional controlBarun Mahata, Alan Cabrera, Daniel A Brenner, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cancer Research|February 6, 2013
mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesisDebasmita Roy, Sang-Hoon Sin, Amy Lucas, et al.
Science Advances|August 25, 2020
Single C-to-T substitution using engineered APOBEC3G-nCas9 base editors with minimum genome- and transcriptome-wide off-target effectsSangsin Lee, Ning Ding, Yidi Sun, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Tailoring a CRISPR/Cas-based Epigenome Editor for Programmable Chromatin Acylation and Decreased CytotoxicityJacob Goell, Jing Li, Barun Mahata, et al.
Scientific Reports|February 17, 2017
Cu<sup>II</sup>(atsm) improves the neurological phenotype and survival of SOD1<sup>G93A</sup> mice and selectively increases enzymatically active SOD1 in the spinal cordJames B Hilton, Stephen W Mercer, Nastasia K H Lim, et al.
Human Molecular Genetics|March 18, 2014
Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brainNastasia K H Lim, Lin W Hung, Terence Y Pang, et al.
ACS Synthetic Biology|February 3, 2025
Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T CellsRosa Selenia Guerra-Resendez, Samantha LeGoff Lydon, Alex J Ma, et al.
Journal of the American Chemical Society|December 21, 2022
Multiplex Base-Editing Enables Combinatorial Epigenetic Regulation for Genome Mining of Fungal Natural ProductsFanglong Zhao, Chunxiao Sun, Zhiwen Liu, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Persistent tailoring of MSC activation through genetic primingMichael A Beauregard, Guy C Bedford, Daniel A Brenner, et al.
Molecular Therapy. Methods & Clinical Development|September 16, 2024
Persistent tailoring of MSC activation through genetic primingMichael A Beauregard, Guy C Bedford, Daniel A Brenner, et al.
Nature Methods|October 9, 2023
Compact engineered human mechanosensitive transactivation modules enable potent and versatile synthetic transcriptional controlBarun Mahata, Alan Cabrera, Daniel A Brenner, et al.
Pageof 10